Stay updated on RPL554 MDI for COPD Treatment Clinical Trial
Sign up to get notified when there's something new on the RPL554 MDI for COPD Treatment Clinical Trial page.

Latest updates to the RPL554 MDI for COPD Treatment Clinical Trial page
- Check5 days agoChange DetectedA recruitment-status notice 'No longer looking for participants' was added, indicating enrollment is closed for this study. New help and navigation sections were added, including How to Read a Study Record, Common Questions, and How to Join a Study.SummaryDifference0.4%

- Check12 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5. This appears to be an internal maintenance update and does not affect the study data.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe page now displays Revision: v3.5.4, replacing the previous Revision: v3.5.3, signaling a new version snapshot of the study page content.SummaryDifference0.0%

- Check41 days agoChange DetectedThe sponsor field now lists Verona Pharma, Inc., a subsidiary of Merck & Co., Inc., as the sponsor. Verona Pharma plc is no longer referenced in the sponsor information.SummaryDifference0.2%

- Check48 days agoChange DetectedThe page now shows a new revision tag (v3.5.3) replacing the previous (v3.5.2), signaling an administrative update. There are no changes to study content or results.SummaryDifference0.0%

- Check62 days agoChange DetectedSite revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

Stay in the know with updates to RPL554 MDI for COPD Treatment Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RPL554 MDI for COPD Treatment Clinical Trial page.